α-Chemokine growth factors for adenocarcinomas; A synthetic peptide inhibitor for α-chemokines inhibits the growth of adenocarcinoma cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 1, 2000, Pages 19-26

  Fujisawa, N ^a   Sakao, Y ^a   Hayashi, S ^b   Hadden III, W A ^a   Harmon, C L ^a,b   Miller, E J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Chemokines; Growth factors; Growth related oncogene; Interleukin 8; Tumor immunity

Indexed keywords

ALPHA CHEMOKINE; ALPHA CHEMOKINE RECEPTOR INHIBITOR; HEXAPEPTIDE; INTERLEUKIN 8; MONOCLONAL ANTIBODY; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL LINE; CELL PROLIFERATION; CLINICAL TRIAL; COLON ADENOCARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR IMMUNITY;

EID: 0033988249     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008460     Document Type: Article

References (38)

1. Ardizzoni A, Bonavia M, Viale M, Baldini E, Mereu C, Verna A, Ferrini S, Cinquegrana A, Molinari S, Mariani GL, Roest GJ, Sharenberg J, Palmer PA, Rosso R, Ropolo F, Raso C (1994) Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer. Cancer 73:1353-1360
2. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Stricter RM (1996) Inhibition if interleukin-8 reduces tumorigenesis of human non-small lung cancer in SCID mice. J Clin Invest 97:2792-2802
3. Baggiolini M, Waltz A, Kunkel SK (1989) Neutrophil-activating pep tide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049
4. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179
5. Bergh JCS (1990) Gene amplification in human lung cancer. Am Rev Respir Dis 142:S20-S26
6. Bolton AE, Hunter WM (1973) The labeling of proteins to high specific radioactivities by conjugation to a 125-I-containing acylating agent: application to the radioimmunoassay. Biochem J 133:529-539
7. Edwards FR (1979) Use of BCG as an adjuvant immunostimulant after resection of carcinoma of the lung: a 2-year assessment of trial of 500 patients. Thorax 34:801-806
8. Figlin RA, Sarna GP (1983) Human leukocyte Interferon (IFN): a phase II trial in non-small cell lung cancer and adenocarcinoma of the colon/rectum (abstract). Proc Am Soc Clin Oncol 2:45
9. Fujisawa N, Hayashi S, Miller EJ (1999a) A synthetic peptide inhibitor for α-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice. Melanoma Res 9:104-114
10. Fujisawa N, Hayashi S, Kurdowska A, Carr FK, Miller EJ (1999b) Inhibition of Groα -induced human endothelial cell proliferation by the α-chemokine inhibitor Antileukinate. Cytokine 11:231-238
11. Garcia de Palazzo IE, Adams GP, Sundareshan P, Wong AJ, Testa JR, Bigner DD, Weiner LM (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 53:3217-3220
12. Hayashi S, Kurdowska A, Miller EJ, Albright ME, Girten BE, Cohen AB (1995) Synthetic hexa-and heptapeptides which inhibit IL-8 from binding to activating human blood neutrophils. J Immunol 154:814-824
13. Hayashi S, Kurdowska A, Cohen AB, Stevens MD, Fujisawa N, Miller EJ (1997) A Synthetic peptide inhibitor for α-chemokines inhibits the growth of melanoma cell lines. J Clin Invest 99:2581-2587
14. Hollinshead A, Stewart THM, Takita H, Dalbow M, Concannon J (1987) Adjuvant specific active lung cancer immunotherapy trials: tumor-associated antigens. Cancer 60:1249-1262
15. Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194:45-48
16. Klastersky J (1995) Therapy of non-small cell lung cancer. Lung Cancer 12 S1:S133-S145
17. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Stricter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801
18. Leong SR, Lowman HB, Liu J, Shire S, Deforge LE, Gillece-Castro BL, McDowell R, Hébert CA (1997) IL-8 single-chain homodimers and heterodimers: interactions with the chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci 6:609-617
19. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowski W, Kownatzki E, Thelen M, Peveri P, Dewald B, vonTscharner V, Walz A, Baggiolini M (1988) Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biologic equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 85:9199-9203
20. Matsushima K, Oppenheim J (1989) Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1:2-13
21. Meropol NJ, Creaven PJ, Petrelli NJ (1995) Metastatic colorectal c ancer: advances in biochemical modulation and new drug development. Semin Oncol 22:509-524
22. Miller EJ, Brelsford WG (1993) Interleukin-8: the major neutrophil chemotaxin in a case of pseudogout. J Rheumatol 20:1250-1252
23. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA (1992) Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 141:1279-1284
24. Miller EJ, Cohen AB, Carr FK, Hayashi S, Chiu CY, Lee-Ng CT, Mullenbach G (1995) High yields of interleukin-8 produced by a synthetic gene expressed in Escherichia coli and purified with a single antibody affinity column. Protein Expr Purif 6:357-362
25. Miller EJ, Nagao S, Carr FK, Noble JM, Cohen AB (1996) Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflammation Res 45:386-392
26. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M (1993) Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294:285-292
27. Mosmann T (1983) Rapid calorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
28. Murphy PM, Tiffany HL (1991) Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283
29. Norgauer J, Metzner B, Schraufstätter I (1996) Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 157:1132-1137
30. Oppenheim J, Zachariae OC, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648
31. Pelton RW, Moses HL (1990) The beta-type transforming growth factor. Am Rev Respir Dis 142:S31-S35
32. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK (1983) Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Res 43:2106-2112
33. Stricter RM, Polverini PJ, Arenberg DA, Waltz A, Opdenakker G, Damme JV, Kunkel SL (1992) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 57:752-762
34. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ (1990) Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis 141:683-686
35. Takita H (1996) Perioperative therapy for locoregional nonsmall-cell lung cancer. J Surg Oncol 62:65-74
36. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor RE, Nakajima M, Hendrix MJ (1991) Characterization of a high invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 47:227-237
37. Wils J (1996) The treatment of advanced gastric cancer. Semin Oncol 23:397-406
38. World Health Organization (1997) World Health Report 1997. URL: http://www.who.ch./whr/1997